Exciting discovery:
🧠Researchers identify genetic variations in APOEε4 carriers that may protect against Alzheimer's, linking protective effects to the extracellular matrix.
Congrats to Caghan Kizil et al. for pioneering insights into AD prevention. #AlzheimersResearch …

Biliyor muydunuz?
Birçok #elektroniksigara , çocuklar ve gençlerin beyin gelişimine zarar verebilecek, bağımlılık yapıcı #nikotin içeriyor.
Gelecek nesillerimizi koruyalım! 🧠✨
T.C. Sağlık Bakanlığı Ankara Üniversitesi Ankara Büyükşehir Yeşilay

Did you know?
Most #ecigarettes contain #nicotine - a highly addictive substance that can harm brain development in kids and teens.
Let’s protect our future generations! 🧠✨
World Health Organization (WHO) Union for International #CancerControl Ankara Üniversitesi

Most #ecigarettes contain #nicotine .

Nicotine is highly addictive and has damaging effects on brain 🧠 development for children and adolescents.

Happy to share our commentary about EV-302 European Urology European Association of Urology (EAU) - Thanks to Markus Eckstein Boris Hadaschik Viktor Grünwald

Identification of patients with low or minimal chances of benefiting from EV/P is crucial, as there are other effective therapies available (eg,…

Bizim için çok heyecan verici bir haberi paylaşmak istiyorum. Yeni çalışmamızda, insanlarda #Alzheimer riskini %71 azaltan bir #genetik değişimi ve bu değişimin etki mekanizmasını açığa çıkardık. Bu bulgu, milyonlarca insanı hastalıktan koruyabilir ve Alzheimer'ın önlenmesi ve…

The Lancet Commission on prostate cancer projects a X2️⃣ 📈of cases by 2040, highlighting the urgent need for innovations in diagnosis & treatment.
👏Kudos to the authors for mapping a path to better men’s health worldwide.

OncoAlert Prostate Cancer Foundation Nick James Advanced Prostate Cancer Consensus Conference…

🫁ALINA: Adjuvant alectinib significantly improves 2-year disease-free survival in resected ALK-positive NSCLC patients (stage IB, II, IIIA) vs. platinum-based chemo: 93.8% vs 63.0% (stage II/IIIA) & 93.6% vs 63.7% (ITT).

🫁Highlights potential shift in post-surgery treatment…

This is an instance when both the median OS and HR fail to adequately capture the efficacy and one needs to look at the curves in full. L+P has an OS Benefit which diminishes over time.

Ramazan Bayramınız Kutlu Olsun
#EidMubarak #EidulFitr2024

Yüksel Ürün Aaron Goodman - “Papa Heme” 𝗡𝗶𝗵𝗮𝗿 𝗗𝗲𝘀𝗮𝗶 MD, DM Nico Gagelmann Tim Fenske Nikhil C. Munshi, MD Vivek Ramaswamy Murali Janakiram Luciano J Costa Less is more 😘

🎉 Join us in celebrating the 20th Anniversary of the publication of the first paper on Circulating Tumor Cells! 🎉 We extend a warm invitation to join us in Granada as we embrace the spirit of scientific inquiry, collaboration, and friendship. Check out the program and speakers…

Once-Weekly Bortezomib Matches Efficacy with Less Discomfort and More Savings!
⭕️A new study finds that once-weekly bortezomib for multiple myeloma shows similar efficacy to twice-weekly dosing but with fewer side effects like peripheral neuropathy.
⭕️This shift could mark a…

Symphony of light and darkness...
Solar eclipse's phases above the Washington Monument.
Photo NASA #Eclipse2024 #SolarEclipse

Ramazan Bayramınız Kutlu Olsun
#EidMubarak #EidulFitr2024

Final Prespecified Overall Survival Analysis of CLEAR, a Phase III Study:
⭕️Final CLEAR trial results: Lenvatinib+pembrolizumab reduces mortality risk by 21% vs sunitinib in advanced RCC.
⭕️While median OS is similar, the combo’s lower HR & tight 95% CI underscore its robust…

The influencers of #Oncology for the last week according to Symplur ✌️🤝
OncoDaily OncoAlert AACR Vivek Subbiah, MD Yüksel Ürün ASCO Cancer Discovery The Innovation Oncology Toni Choueiri, MD Top Biomedical Science

#oncodaily #oncology #Cancer

#EAU24 updated Adjuvan IO-based regimen in urothelial cancer!
European Association of Urology (EAU) OncoAlert Bladder Cancer Advocacy Network Fight Bladder Cancer ASCO ESMO - Eur. Oncology Uromigos UroToday.com Tom Powles Matt Galsky

☀️🌑🌙Wow! Watching the celestial event AACR #AACR24 brings everyone together. #CancerMoonshot 👉🏼We choose to go to the moon 🌙 ☀️Stunning images of #Eclipse2024 with the amazing Clayton Boldt, Ph.D. Aubrey Bloom #AACR24 🎯🧬🚀 AACR AACRPres AACR_CEO Cancer Discovery Clinical Cancer Research OncoAlert…